AB
TARS icon

Amalgamated Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Amalgamated Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,231
Closed -$101K – 2688
2025
Q4 		$101K Sell
1,231
-43
-3% -$3.21K ﹤0.01% 1699
2025
Q3 		$76K Hold
1,274
– – ﹤0.01% 1743
2025
Q2 		$52K Hold
1,274
– – ﹤0.01% 1823
2025
Q1 		$65K Buy
1,274
+295
+30% +$14.6K ﹤0.01% 1751
2024
Q4 		$54K Hold
979
– – ﹤0.01% 1822
2024
Q3 		$32K Hold
979
– – ﹤0.01% 1981
2024
Q2 		$27K Hold
979
– – ﹤0.01% 2022
2024
Q1 		$36K Sell
979
-1,468
-60% -$43.2K ﹤0.01% 1947
2023
Q4 		$50K Buy
2,447
+163
+7% +$2.72K ﹤0.01% 2253
2023
Q3 		$41K Buy
2,284
+394
+21% +$6.97K ﹤0.01% 2334
2023
Q2 		$34K Hold
1,890
– – ﹤0.01% 2484
2023
Q1 		$24K Sell
1,890
-405
-18% -$5.92K ﹤0.01% 2585
2022
Q4 		$34K Hold
2,295
– – ﹤0.01% 2595
2022
Q3 		$39K Hold
2,295
– – ﹤0.01% 2567
2022
Q2 		$34K Buy
2,295
+989
+76% +$14.8K ﹤0.01% 2656
2022
Q1 		$22K Buy
+1,306
New +$24.2K ﹤0.01% 2782

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Amalgamated Bank's TARS Position: Q1 2026 in Review

Amalgamated Bank sold out of Tarsus Pharmaceuticals (TARS) in Q1 2026, closing a stake of 1,231 shares — an estimated $101K sold.

Amalgamated Bank first reported a position in TARS in Q1 2022 and held it in 16 quarters. The position peaked at $101K in Q4 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Amalgamated Bank reported no remaining Tarsus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,231 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $101K.
  • Amalgamated Bank first reported a position in Tarsus Pharmaceuticals in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Tarsus Pharmaceuticals position peaked at $101K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.